“Peter M. Glazer, MD, PhD, Robert E. Hunter Professor and chair, department of therapeutic radiology, Yale School of Medicine, New Haven, Conn. For discovering that tumor hypoxia causes genetic instability and that IDH1 mutations suppress DNA repair in cancers, conferring vulnerability to radiation and PARP inhibitors. He developed novel DNA repair inhibitors for cancer therapy and triplex-forming oligonucleotides for gene editing. His work led to multiple new clinical trials for cancer.”
In collaboration with HOPE, Dr. Glazer works with triplex-forming oligonucleotides targeting the latent HIV provirus.
Check out this article Glazer and Omer Are New Members of National Academy of Medicine